Evaluation of lactose and milk intolerance, and bone mineral density in indian patients with inflammatory bowel disease

National Medical Journal of India

Volumn 25, Issue 6, 2012, Pages 327-331

  Gupta, Richa ^a   Makharia, Govind ^a   Khadgawat, Rajesh ^a   Yadav, Rajkumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; STEROID;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIETARY INTAKE; DISEASE DURATION; ENTERITIS; FEASIBILITY STUDY; FEMALE; HUMAN; HYDROGEN BREATH TEST; INDIA; LACTOSE INTOLERANCE; MALE; MILK INTOLERANCE; OSTEOPENIA; OSTEOPOROSIS; PILOT STUDY; PROSPECTIVE STUDY; ULCERATIVE COLITIS;

BONE DENSITY; BONE DISEASES, METABOLIC; HUMANS; INDIA; INFLAMMATORY BOWEL DISEASES; LACTOSE INTOLERANCE; OSTEOPOROSIS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84878777624     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429.
2. Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health. Inflamm Bowel Dis 2006;12:38-46.
3. Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389-396.
4. Mikocka-Walus AA, Turnbull DA, Andrews JM, Moulding NT, Holtmann GJ. The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008;28:475-483.
5. Riordan AM, Hunter JO, Crampton JR, Neale G, Cowan RE, Davidson AR, et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993;342:1131-1134.
6. Axelsson C, Jarnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol 1977;12:89-95.
7. Rocchio MA, Cha CJ, Haas KF, Randall HT. Use of chemically defined diets in the management of patients with acute inflammatory bowel disease. Am J Surg 1974;127:469-475.
8. Mishkin S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr 1997;65:564-567.
9. Kochhar R, Mehta SK, Goenka MK, Mukherjee JJ, Rana SV, Gupta D. Lactose intolerance in idiopathic ulcerative colitis in north Indians. Indian J Med Res 1993;98:79-82.
10. Ginard D, Riera J, Bonet L, Barranco L, Reyes J, Escarda A, et al. Lactose malabsorption in ulcerative colitis: A case-control study. Gastroenterol Hepatol 2003;26:469-474.
11. Mishkin S. Controversies regarding the role of dairy products in inflammatory bowel disease. Can J Gastroenterol 1994;8:205-212.
12. Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol 1994;89:872-877.
13. Brown AC, Rampertab SD, Mullin GE. Existing dietary guidelines for Crohn's disease and ulcerative colitis. Expert Rev Gastroenterol Hepatol 2011;5:411-425.
14. Andreassen H, Rungby J, Dahlerup JF, Mosekilde L. Inflammatory bowel disease and osteoporosis. Scand J Gastroenterol 1997;32:1247-1255.
15. Rodriguez-Bores L, Barahona-Garrido J, Yamamoto-Furusho JK. Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol 2007;13:6156-65.
16. Katz S. Osteoporosis in patients with inflammatory bowel disease: Risk factors, prevention, and treatment. Rev Gastroenterol Disord 2006;6:63-71.
17. Bernstein CN, Leslie WD. Osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther 2004;19:941-952.
18. Khadgawat R, Makharia GK, Puri K. Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India. Indian J Gastroenterol 2008;27:103-106.
19. Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci 2007;52:33-39.
20. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut 2006;55:749-753.
21. Barios Madrid R, Salama Benerroch H, Morán Sánchez S, Gallardo Sánchez F, Albadalejo Meroño A, Mercader Martínez J. Lactose malabsorption in patients with inflammatory bowel disease without activity: Would it be necessary to exclude lactose products in the diet of all patients. An Med Interna 2004;21:212-214.
22. Vernia P, Di Camillo M, Marinaro V. Lactose malabsorption, irritable bowel syndrome and self-reported milk intolerance. Dig Liver Dis 2001;33:234-239.
23. Vesa T, Korpela R, Sahi T. Tolerance to small amounts of lactose in lactose maldigesters. Am J Clin Nutr 1996;64:197-201.
24. Baroja ML, Kirjavainen PV, Hekmat S, Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol 2007;149:470-479.
25. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28:410-415.
26. Pigot F, Roux C, Chaussade S, Hardelin D, Pelleter O, Du Puy Montbrun T, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992;37:1396-1403.
27. Miheller P, Lorinczy K, Lakatos PL. Clinical relevance of changes in bone metabolism in inflammatory bowel disease. World J Gastroenterol 2010;16:5536-5542.
28. Ezzat Y, Hamdy K. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases. Int J Rheum Dis 2010;13: 259-265.
29. Haugeberg G, Vetvik K, Stallemo A, Bitter H, Mikkelsen B, Stokkeland M. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: Cross-sectional data from a population-based study. Scand J Gastroenterol 2001;36:759-765.
30. Silvennoinen JA, Karttunen TJ, Niemelä SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71-76.
31. Orlic ZC, Turk T, Sincic BM, Stimac D, Cvijanovic O, Maric I, et al. How activity of inflammatory bowel disease influences bone loss. J Clin Densitom 2010;13: 36-42.
32. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study. Gut 1997;40:313-319.
33. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107: 1031-1039.
34. Arya V, Bhambri R, Godbole MM, Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int 2004;15:56-61.